Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001410939-23-000043
Filing Date
2023-04-05
Accepted
2023-04-05 16:13:16
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A additionalproxymaterialsfo.htm DEFA14A 14016
2 a2023040503sjda_ivericxbio.jpg GRAPHIC 665032
3 a2023040503sjda_ivericxbioa.jpg GRAPHIC 299134
  Complete submission text file 0001410939-23-000043.txt   1342390
Mailing Address 8 SYLVAN WAY PARSIPPANY NJ 07054
Business Address 8 SYLVAN WAY PARSIPPANY NJ 07054 (609) 474-6755
IVERIC bio, Inc. (Filer) CIK: 0001410939 (see all company filings)

EIN.: 208185347 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36080 | Film No.: 23802681
SIC: 2834 Pharmaceutical Preparations